Encoded Therapeutics develops gene therapies for pediatric CNS disorders using a cell-selective targeting and regulation platform. Their approach offers unprecedented gene specificity and cell selectivity, allowing for the targeting of a range of disease mechanisms. Encoded's technology is compatible with any delivery system and has broader therapeutic potential beyond CNS disorders.